Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo‐Controlled Trial in Adults With Systemic Sclerosis

OBJECTIVE: To assess the safety and efficacy of lenabasum in diffuse cutaneous systemic sclerosis (dcSSc). METHODS: A randomized, double‐blind, placebo‐controlled, phase II study was conducted at 9 SSc clinics in the US. Adults with dcSSc of ≤6 years’ duration who were receiving stable standard‐of‐c...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Arthritis Rheumatol
Hlavní autoři: Spiera, Robert, Hummers, Laura, Chung, Lorinda, Frech, Tracy M., Domsic, Robyn, Hsu, Vivien, Furst, Daniel E., Gordon, Jessica, Mayes, Maureen, Simms, Robert, Lafyatis, Robert, Martyanov, Viktor, Wood, Tammara, Whitfield, Michael L., Constantine, Scott, Lee, Elizabeth, Dgetluck, Nancy, White, Barbara
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2020
Témata:
Systemic Sclerosis
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7497006/
https://ncbi.nlm.nih.gov/pubmed/32336038
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.41294
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky